Skip to main content



Identification of small molecules tuning phase transitions to treat neurological disorders

Luna Bioscience, Inc

Rosevix (Rosziqumab) A ROS1 Biologic for Invasive Cancers

Neurolexa Therapeutics

Treating Epilepsy in an Orphan Genetically-Defined Disorder, Tuberous Scelerosis Complex (TSC)

Direct intralesional mTOR inhibition for targeted treatment of sporadic and syndromic venous and lymphatic malformations

NCS1 - A New Target for Mood Disorders and Wolfram Syndrome

Cell Permeable Miniature Proteins

Subscribe to Orphan